Clinical Indication

Prevention of skeletal related events in adults with bone metastases from solid tumours other than prostate

Comments

Full SCA

Date of classification

May 2014

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.